搜索
BioLine RX Ltd
BLRX添加自选
3.285USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
14.29M总市值
亏损市盈率 TTM
关于 BioLine RX Ltd 公司
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltd简介
公司代码BLRX
公司名称BioLine RX Ltd
上市日期Jan 30, 2007
CEOSerlin (Philip Adam)
员工数量28
证券类型Depository Receipt
年结日Jan 30
公司地址Modi'in Technology Park
城市MODIIN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编7177871
电话97286429100
网址https://www.biolinerx.com/
公司代码BLRX
上市日期Jan 30, 2007
CEOSerlin (Philip Adam)
BioLine RX Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
常见问题
BioLine RX Ltd的前五大股东是谁？
BioLine RX Ltd 的前五大股东如下：Dr. Aharon Schwartz, Ph.D.
有多少机构持有BioLine RX Ltd(BLRX)的股份？
截至2026Q1，共有60家机构持有BioLine RX Ltd的股份，合计持有的股份价值约为46.33K，占公司总股份的1.06%。与2025Q4相比，机构持股有所增加，增幅为-104547.00。